MLA
Gulec, Seza A, et al. Safety and Efficacy of Y-90 Microsphere Treatment In Patients with Primary and Metastatic Liver Cancer: The Tumor Selectivity of the Treatment As a Function of Tumor to Liver Flow Ratio. BioMed Central Ltd, 2007. https://doi.org/10.17615/kfq4-mc35
APA
Gulec, S., Mesoloras, G., Dezarn, W., Mc Neillie, P., & Kennedy, A. (2007). Safety and efficacy of Y-90 microsphere treatment in patients with primary and metastatic liver cancer: The tumor selectivity of the treatment as a function of tumor to liver flow ratio. BioMed Central Ltd. https://doi.org/10.17615/kfq4-mc35
Chicago
Gulec, Seza A, Geraldine Mesoloras, William A Dezarn, Patrick Mc Neillie, and Andrew S Kennedy. 2007. Safety and Efficacy of Y-90 Microsphere Treatment In Patients with Primary and Metastatic Liver Cancer: The Tumor Selectivity of the Treatment As a Function of Tumor to Liver Flow Ratio. BioMed Central Ltd. https://doi.org/10.17615/kfq4-mc35